CGM Cost Without Insurance: What One Sensor Costs, and What the Price Includes
Without insurance, a continuous glucose monitor through ACT 2 Health costs $189. That buys one 14-day sensor and one visit with a licensed clinician, and it is a one-time charge: there is no subscription, no sensor pack and no membership. The eligibility review is free. If you meet Medicare's or your insurer's criteria for a CGM, though, paying through that coverage will probably cost you less. This page explains both routes.
Every ACT 2 price is on the pricing page. Whether a CGM will tell you anything useful is a separate question, covered on the CGM page. It is worth answering before you buy one.
Medically reviewed by Johnathan Chance Miller, M.D. —
Physician and holistic medicine practitioner blending rigorous clinical training with an integrative approach to longevity. Full bio
What ACT 2 charges for a CGM
| Treatment | Option | Price | How it is billed |
|---|---|---|---|
| Continuous Glucose Monitor | 1 sensor | $189 | One-time |
The price is a single one-time charge for a single sensor. There is one option, so there is nothing to compare between tiers. What the $189 covers:
- One visit with a licensed clinician. The clinician decides whether a sensor is appropriate for you before one is prescribed. A CGM is prescribed only when medically appropriate, and clinicians do not prescribe one to anyone with a history of disordered eating.
- One 14-day sensor, shipped to you. You wear it for the period the manufacturer's instructions allow, then it is done.
- Your data, in a written results report, to set beside your labs; if you are in a treatment program with ACT 2, your prescribing clinician uses the trace to guide what changes.
The eligibility screen is free. If the answer is no, you pay nothing. Lab work is priced separately. The new-patient welcome offer does not apply to CGM. Shipping and taxes, where they apply, are shown before you pay.
One thing the sensor does not do: a CGM does not diagnose diabetes. A diagnosis rests on laboratory blood tests, which is why the sensor is usually read beside a blood panel rather than on its own.
Why one sensor is the sensible starting point
ACT 2's CGM is sold one sensor at a time, bought once rather than monthly. The booking page describes it the same way: one 14-day sensor, a good way to see your own data before committing to a program.
That matches how most people without diabetes actually use a CGM. A single wear shows what your glucose does across two ordinary weeks of meals, sleep, work and exercise. For many people, that one picture is enough to answer the question they came with, and they do not need a second one. For others, the trace raises a question that a blood panel or a treatment program answers better than more sensor time would.
Because the price is per sensor and there is no pack, nothing is lost by starting with one. You are not buying ahead of a decision you have not made yet.
What a second wear costs
If you and your clinician decide a repeat wear is worth it, for example after a change in treatment or several months into a weight program, a second sensor is bought the same way as the first, at the same price. Two sensors come to $378 in total. There is no pack discount to lose by buying them separately and no commitment to buying the second at all.
This page keeps the arithmetic per sensor. ACT 2's device is not named on the site, and how long a sensor runs is set by the manufacturer's instructions, so the only duration this page uses is the one the booking page uses: 14 days.
What a first wear, and a year, can cost
A realistic first purchase is a single wear read against a blood panel:
- One sensor plus a comprehensive panel: $388. This assumes one sensor and one comprehensive panel at $199.
- A repeat-wear year: $776. This assumes two sensors across the year, each bought separately, and two comprehensive panels.
Lab testing is not currently available in New York, New Jersey or Rhode Island. What each panel costs is on the lab testing cost page.
Does Medicare cover a CGM?
Medicare covers a CGM for some people with diabetes, and for them it is often the cheaper route. It pays through Part B as durable medical equipment. According to Medicare.gov and the CMS coverage policy for glucose monitors, you must meet all of these conditions:
- You have diabetes.
- You take insulin, or you have a documented history of problematic low blood sugar. CMS defines that as recurrent significant lows that persist despite changes to treatment, or at least one severe low that needed someone else's help.
- A practitioner prescribes the CGM in line with its FDA indications and judges that you (or your caregiver) have enough training to use it.
- You had an in-person or Medicare-approved telehealth visit about your diabetes control within the six months before the order. Follow-up visits then continue every six months to keep coverage.
If you qualify, you pay 20% of the Medicare-approved amount after the Part B deductible, provided the supplier accepts assignment. That will usually be less than self-pay.
Medicare does not cover a CGM for someone without diabetes who wants to see their glucose patterns. That is the group ACT 2's service is mostly built for. Commercial plans set their own criteria. NIDDK advises checking with your plan or Medicare before buying, and that is the right first step. ACT 2 does not bill insurance, Medicare or Medicare Advantage. HSA and FSA questions belong on the pricing and insurance FAQ and the FSA and HSA year-end page.
Over-the-counter CGMs change the comparison
In March 2024 the FDA cleared the first over-the-counter CGM, for adults who do not use insulin and do not have problematic low blood sugar. For some people, buying one directly is a reasonable, lower-cost choice. ACT 2's own CGM page says so.
This page does not repeat the device-by-device comparison. The OTC vs prescription page covers it. The cost question comes down to one thing: ACT 2's price pays for the clinician visit and the written results as well as the sensor, and for the clinician's use of the trace if you go on to a treatment program. If you only want to see the numbers, an over-the-counter sensor is the cheaper route.
Frequently asked questions
A CGM through ACT 2 Health costs $189 without insurance. That is a one-time charge for one 14-day sensor and one visit with a licensed clinician, with your results in a written report to set beside your labs. There is no monthly plan and no sensor pack. The eligibility screen is free, and the welcome offer does not apply to CGM.
One. ACT 2 sells a single 14-day sensor for $189, bought once. The price also covers a visit with a licensed clinician and a reading of your trace. If a repeat wear is worth doing later, a second sensor is bought separately at the same price.
The sensor ACT 2 supplies is listed as a 14-day sensor. The exact wear period is set by the device's manufacturer and its instructions, and the clinician will tell you how long to keep yours on. One sensor means one wear, so a single purchase gives you one two-week window of data.
Yes. There is no pack to commit to and no subscription to join: each sensor is a separate $189 purchase, so two sensors come to $378. Most people without diabetes find one wear answers their question, so the sensible order is to wear one, read it with your clinician, and decide then whether a second is worth it.
Medicare Part B covers a CGM for people with diabetes who take insulin or have a documented history of problematic low blood sugar. The CGM must be prescribed in line with its FDA indications after a qualifying visit within the previous six months. Covered patients pay 20% of the Medicare-approved amount after the Part B deductible. Medicare does not cover a CGM for people without diabetes. ACT 2 does not bill Medicare.
A prescription CGM is often cheaper through insurance if you meet your plan's coverage criteria. Medicare's, for example, require diabetes plus insulin use or a history of problematic low blood sugar. If you qualify, paying self-pay prices at ACT 2 would likely cost you more, so check your plan's criteria first. ACT 2's CGM, at $189 for one sensor, is mainly for people whom insurance would not cover.
Yes. Since March 2024 the FDA has cleared CGMs for over-the-counter sale to adults who do not use insulin and do not have problematic low blood sugar. For someone who only wants to see their numbers, buying one directly is a reasonable choice. ACT 2's price also covers a visit with a licensed clinician, a reading of your trace and a written interpretation.
Where this fits in your plan
The first question is whether a CGM will change a decision for you. The CGM page answers that, and the CGM vs A1c and fasting glucose page explains what a sensor can and cannot tell you. If you are on a weight program, using a CGM on a GLP-1 is the most common reason a second wear comes up.
We measure first. Then we act.
References
- Medicare.gov. Continuous glucose monitors: coverage, eligibility and costs. Centers for Medicare & Medicaid Services. https://www.medicare.gov/coverage/therapeutic-continuous-glucose-monitors
- Centers for Medicare & Medicaid Services. Local Coverage Determination L33822: Glucose Monitors (CGM coverage criteria). Medicare Coverage Database. https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=33822
- Medicare.gov. Durable medical equipment (DME) coverage: Part B deductible and coinsurance. https://www.medicare.gov/coverage/durable-medical-equipment-dme-coverage
- U.S. Food and Drug Administration. FDA Clears First Over-the-Counter Continuous Glucose Monitor. Press announcement, March 5, 2024. https://www.fda.gov/news-events/press-announcements/fda-clears-first-over-counter-continuous-glucose-monitor
- National Institute of Diabetes and Digestive and Kidney Diseases. Continuous Glucose Monitoring. National Institutes of Health. https://www.niddk.nih.gov/health-information/diabetes/overview/managing-diabetes/continuous-glucose-monitoring
- U.S. Food and Drug Administration. Blood Glucose Monitoring Devices. https://www.fda.gov/medical-devices/in-vitro-diagnostics/blood-glucose-monitoring-devices
- Back toPricing
- CGMTwo weeks of real glucose data to set beside your labs, and an honest answer up front about whether you need it at all.Read
- OTC vs prescription CGMThree glucose monitors are sold over the counter, and they are good sensors. What each is built for, what a prescription adds, and when to just buy one.Read
- CGM in perimenopauseEstrogen keeps muscle sensitive to insulin, and losing it changes what glucose does. What a two-week sensor run shows across the transition.Read
- Pricing and insurance FAQWhat ACT 2 Health costs, what each price includes, whether insurance is accepted, how HSA and FSA work, billing cadence, cancellation and shipping.Read
How we write and review our content
ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.
Diagnostic testing does not diagnose or rule out disease on its own and is interpreted by a licensed provider alongside your history and examination.
All medical decisions are made solely by licensed healthcare professionals. Medications are prescribed only when medically necessary. GLP-1 medications are not suitable for everyone. Results may vary.
Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.
Prices shown are current catalog prices and are confirmed at your eligibility review; Medicare criteria are summarized from CMS and Medicare.gov and your own coverage is decided by your plan.